MediciNova
MNOV
#10118
Rank
HK$0.51 B
Marketcap
HK$10.51
Share price
-1.47%
Change (1 day)
-0.06%
Change (1 year)

EPS for MediciNova (MNOV)

EPS in 2026 (TTM): -HK$1.88

According to MediciNova's latest financial reports the company's current EPS (TTM) is -HK$1.88. In 2025 the company made an earnings per share (EPS) of -HK$1.88 a decrease over its 2024 EPS that were of -HK$1.80.

EPS history for MediciNova from 2001 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$1.88-0.41%
2025-HK$1.884.35%
2024-HK$1.8035.29%
2023-HK$1.33-41.38%
2022-HK$2.2838.1%
2021-HK$1.65-32.26%
2020-HK$2.433.33%
2019-HK$2.35-16.67%
2018-HK$2.8212.5%
2017-HK$2.51-3.03%
2016-HK$2.59-0%
2015-HK$2.59-13.16%
2014-HK$2.98100%
2013-HK$1.49-71.21%
2012-HK$5.18-45%
2011-HK$9.41-26.38%
2010-HK$12.79-2.98%
2009-HK$13.18-7.69%
2008-HK$14.28-56.25%
2007-HK$32.6418.18%
2006-HK$27.6222.22%
2005-HK$22.59-99.82%
2004-HK$12,4921182.05%
2003-HK$974.38-10.4%
2002-HK$1,088286.13%
2001-HK$281.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$55.07-3,025.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$221.43-11,860.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$20.08-1,166.53%๐Ÿ‡ซ๐Ÿ‡ท France
Titan Pharmaceuticals
TTNP
-HK$34.44 1,729.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$7.30-487.50%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
HK$10.75-670.83%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel